Jinding Capital

Jinding Capital is a Chinese private equity and venture capital firm investing in various sectors.

The firm focuses on early-stage to late-stage investments across industries such as energy storage, e-commerce, food and beverage, healthcare, manufacturing, medical devices, semiconductors, energy, pet products, and batteries.

Jinding Capital has a track record of 45 investments, with an average round size of $12 million, and has led 10 of these investments. The firm has a follow-on index of 0.09 and has achieved one exit. Its peak activity year was 2023.

The firm's investment strategy is research-driven and value-oriented, aiming to uncover mega trends and big opportunities in China's future economy. Jinding Capital is committed to enabling industry leaders to become world-class champions.

The team comprises veterans from leading global and local investment firms, combining fund management industry best practices. They have generated long-term attractive investment returns over 15 years in China, offering deep experience, local expertise, and global perspectives.

Jinding Capital's portfolio includes companies such as Bloomage Biotech, Giant Biogene, Gaussian Robotics, 4Paradigm, Miniso, Deerma, Sunwoda Electric Vehicle Battery, JD Energy, and FHS. These investments span various sectors, including biotechnology, robotics, artificial intelligence, retail, consumer electronics, and clean energy.

The firm's headquarters are located at 14/F, China Central Place Tower 1, No. 81 Jianguo Road, Chaoyang District, Beijing 100025, China. For inquiries, they can be contacted via email at info@jindingcapital.com.cn or by phone at 010-50892700.

Jinding Capital's official website is https://www.jindingcapital.com.cn.